News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Corriente Advisors, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/08/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/15/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/15/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/15/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/16/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/15/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2022 |
SC 13G/A
| Corriente Advisors, LLC reports a 0% stake in Cue Biopharma, Inc. |
| 02/14/2022 |
SC 13G/A
| Corriente Advisors, LLC reports a 0% stake in TFF Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| Corriente Advisors, LLC reports a 0% stake in Cardiff Oncology, Inc. |
| 11/15/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/18/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/16/2021 |
SC 13G
| Corriente Advisors, LLC reports a 6.1% stake in TFF Pharmaceuticals, Inc. |
| 02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G
| Corriente Advisors, LLC reports a 5.7% stake in Cardiff Oncology, Inc. |
| 11/03/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/13/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/18/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/13/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/10/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/23/2020 |
SC 13G
| Corriente Advisors, LLC reports a 6.1% stake in Nautilus, Inc. |
| 11/26/2019 |
SC 13G/A
| Corriente Advisors, LLC reports a 4.9% stake in Maxar Technologies Inc. |
| 11/20/2019 |
SC 13G
| Corriente Advisors, LLC reports a 5% stake in Maxar Technologies Inc. |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/23/2018 |
SC 13G
| Corriente Advisors, LLC reports a 7.3% stake in Catabasis Pharmaceuticals, Inc. |
| 11/14/2013 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/14/2013 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 05/15/2013 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 02/14/2013 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 11/14/2012 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 08/14/2012 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
|
|
|